Preoperative chemoradiotherapy in cancer of the thoracic esophagus

Diseases of the Esophagus

Volumn 16, Issue 1, 2003, Pages 9-16

  Terrosu, Giovanni ^a   Cedolini, C ^a   Bresadola, V ^a   Baccarani, U ^a   Uzzau, A ^a   Signor, M ^a   Fongione, S ^a   Buffoli, A ^a   Iop, A ^b   Vigevani, E ^c   Sacco, C ^a   Cartei, G ^d   Bresadola, F ^a  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

^b Latisana Hospital   (Italy)

^c Tolmezzo Hospital   (Italy)

^d CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG RESPONSE; DRUG TOLERABILITY; DRUG TOXICITY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HEART FAILURE; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; NEPHROTOXICITY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; THORACOTOMY; TREATMENT OUTCOME; TREATMENT PLANNING;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DRUG ADMINISTRATION SCHEDULE; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROBABILITY; PROSPECTIVE STUDIES; RADIATION DOSAGE; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; THORAX; TREATMENT OUTCOME;

EID: 0038629467     PISSN: 11208694     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2050.2003.00280.x     Document Type: Article

References (28)

1. Muller J M, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg 1990; 77: 845-857.
2. Miller A B, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207-214.
3. Urba S. Combined-modality treatment of esophageal cancer. Oncology 1997; 11 (9 Suppl.): 63-67.
4. Geh J I, Crellin A M, Glynne-Jones R. Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer. Br J Surg 2001; 88: 338-356.
5. Franklin R, Steigher Z, Vaishampayan G et al. Combined modality therapy for esophageal squamous cell carcinoma. Cancer 1983; 51: 1062-1071.
6. Leichman L, Herskovic A, Leichman C G et al. Nonoperative therapy for squamous- cell cancer of the esophagus. J Clin Oncol 1987; 5: 365-370.
7. Forastiere A A, Orringer M B, Perez Tamayo C, Urba S G, Zahurak M. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: Final report. J Clin Oncol 1993; 11: 1118-1123.
8. Jones D R, Detterbeck F C, Egan T M, Parker, Jr, L A Bernard S A, Tepper JE. Induction chemoradiotherapy followed by esophagectomy in patients with carcinoma of the esophagus. Ann Thor Surg 1997; 64: 185-195.
9. Le Prise E, Etienne P L, Meunier B et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994; 73: 1779-1784.
10. Walsh T N, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy T P. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335: 462-477.
11. Bosset J F, Gignoux M, Triboulet J P et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Eng J Med 1997; 337: 161-167.
12. Bates B A, Detterbeck F C, Bernard S A, Qaqish B F, Tepper J E. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol 1996; 14: 156-163.
13. Forastiere A A, Heitmiller R F, Lee D J et al. Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus. Cancer J Sci Am 1997; 3: 144-152.
14. MacFarlane S D, Hill L D, Jolly P C, Kozarek R A, Anderson R P. Improved results of surgical treatment for esophageal and gastroesophageal junction carcinomas after pèreoperative combined chemotherapy and radiation. J Thorac Cardiovasc Surg 1988; 95: 415-422.
15. Poplin E, Fleming T, Leichman L. et al. Combined therapies for squamous cell carcinoma of the esophagus: A Southwest Oncology Group Study (SWOG-8037). J Clin Oncol 1987; 5: 622-628.
16. Vogel S B, Mendenhall W M, Sombeck M D, Marsh R, Woodward E R. Downstaging of esophageal cancer after preoperative radiation and chemotherapy. Ann Surg 1995; 221: 685-695.
17. Reed C E. Surgical management of esophageal carcinoma. Oncologist 1999; 4: 95-105.
18. Aldestein D J, Rice T W, Becker M et al. Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery in patients with esophageal carcinoma. Cancer 1997; 80: 1011-1020.
19. Hickey K, Grehan D, Reid I M, O'Brian S, Walsh T N, Hennessy T P. Expression of epidermal growth factor receptor and proliferating cell nuclear antigen predicts response of esophageal squamous cell carcinoma to chemoradiotherapy. Cancer 1994; 74 (6): 1693-1698.
20. Ribeiro, Jr, U, Finkelstein S D, Safatle-Ribeiro A V et al. p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma. Cancer 1998; 83: 7-18.
21. Samejima R, Kitajima Y, Yunotani S, Miyazaki K. Cyclin D1 is a possible predictor of sensivity to chemoradiotherapy for esophageal squamous cell carcinoma. Anticancer Res 1999; 19 (6C): 5515-5521.
22. Imdahl A, Jenkner J, Ihling C, Ruckauer K, Farthmann E H. Is MIB-1 proliferation index a predictor for response to neoadjuvant therapy in patients with esophageal cancer? Am J Surg 2000; 179: 514-520.
23. Steiger Z, Franklin R, Wilson R F et al. Complete eradication of squamous cell carcinoma of the esophagus with combined chemotherapy and radiotherapy. Am Surg 1981; 47: 95-98.
24. Cordiano C, Laterza E, Urso S U, Castaldini G. Neoadjuvant chemoradiotherapy in esophageal cancer. Chir Ital 1994; 46: 11-15.
25. Keller S M, Ryan L M, Coia L R et al. High dose chemoradiotherapy followed by esophagectomy for adenocarcinoma of esophagus and gastroesophageal junction: Results of a phase II study of the Eastern Cooperative Oncology Group. Cancer 1998; 83: 1908-1916.
26. Raoul J L, LePrise E, Meunier B, Heresbach D, Campion J P, Launois B. Neoadjuvant chemoradiotherapy hyperfractionated radiotherapy with concurrent low-dose chemotherapy for squamous cell esophageal carcinoma. Int Radiat Oncol Biol Phys 1998; 42: 29-34.
27. Gray J R, Meluch A A, Kalman L, O'Rourke T, Thomas M, Greco F A, Hainsworth J D. Neoadjuvant paclitaxel/carboplatin/5FU/radiation therapy for localized esophageal cancer. Update of a Minnie Pearl Cancer Research Network phase II trial. Proc ASCO 1999; 18: A1040.
28. Nygaard K, Hagen S, Hansen H S et al. Preoperative radiotherapy prolongs survival in operable esophageal carcinoma. A randomized, multicenter study of preoperative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992; 16: 1104-1110.